Guiding Principles of Good AI Practice in Drug Development
The European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) have jointly established new AI principles in drug development to reduce regulatory divergence.
The European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) have jointly established new AI principles in drug development to reduce regulatory divergence.
A number of opportunities are now open for industry partners seeking meaningful visibility and collaboration at the flagship event of the in silico medicine community.
The new Slack channel dedicated to the young scientists community is online. Come join us!
The second and final year of the current Young Scientists Committee kicks off with new webinars, podcast contributions, community spaces, and long-term initiatives designed to support VPH student members throughout their early scientific careers.
Could in silico medicine make healthcare equally precise for all?
On 21 and 27 of January 2026, the VPH Society is organising two exclusive online briefing sessions to present the latest updates in the policy and regulatory context and how this is effecting the in silico medicine field.
In 2025, VPH collaborated with Altertox with the aim of engaging with policy makers in the European Parliament on the topic of in silico medicine. In this interview, we share insights on how to translate scientific advances into policy-relevant outputs.
On 9 December 2025, VPH was invited to present high level pitch at the EMA Annual Data forum, on the how digital twins could shape the future trends in evidence generation.
On 12 December 2025, the VPH Society hosted MEP Liesbet Sommen at University Hospital Gasthuisberg, Leuven. The meeting served as a strategic dialogue on the role of Virtual Human Twins (VHTs) and AI in securing Europe’s leadership in medical technology.
Discover the recently published papers from our community!
VPH participated in the Research School on Digital Twins of the Human Body in Trieste, supporting the dissemination of advanced modelling, simulation, and high-performance computing approaches that underpin next-generation digital twins in healthcare.